<b>Conclusions:</b><i>CP</i>, <i>SLC25A13</i>, and <i>SLC38A2</i> emerge as clinically relevant glutamine-associated metabolic regulators in GBM, linking redox regulation, mitochondrial metabolite exchange, and glutamine-driven growth signaling. Here, SLC38A2 is linked to glioblastoma.